Munafa Stock Market Course + Intraday & FNO calls 
Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for NASDAQ stock ARWR Arrowhead Pharmaceuticals. Dated: 22 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 58.06 and Closed at: 58.36, which is -0.82% of previous session's close. It moved within a range of 56.97 and 59.90
The session was a Bullish session with an average volume of 1036500, which is -32.32% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 57.67 and resistance for tomorrow is 60.6
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 56.92, 55.48 resistance for tomorrow's hourly charts is 59.85, 61.34
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 58.77 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 61.3 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 73.17 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 76.96 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 72.12 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 61.3 and 200 DMA is at 72.12, while 50 DMA and 100 DMA are at 73.17 and 76.96 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 61.3 and 20 EMA is at 61.94
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Thu Oct | 58.36 | 61.3 | 61.94 |
| 21 Wed Oct | 58.84 | 61.68 | 62.32 |
| 20 Tue Oct | 58.92 | 62.09 | 62.69 |
| 19 Mon Oct | 57.23 | 62.73 | 63.09 |
| 16 Fri Oct | 55.90 | 63.31 | 63.71 |
| 15 Thu Oct | 58.50 | 63.84 | 64.53 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 73.17 and 50 EMA is at 69.1
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Thu Oct | 58.36 | 73.17 | 69.1 |
| 21 Wed Oct | 58.84 | 73.75 | 69.54 |
| 20 Tue Oct | 58.92 | 74.36 | 69.98 |
| 19 Mon Oct | 57.23 | 74.95 | 70.43 |
| 16 Fri Oct | 55.90 | 75.56 | 70.97 |
| 15 Thu Oct | 58.50 | 76.15 | 71.59 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 76.96 and 100 EMA is at 72.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Thu Oct | 58.36 | 76.96 | 72.32 |
| 21 Wed Oct | 58.84 | 77.08 | 72.6 |
| 20 Tue Oct | 58.92 | 77.25 | 72.88 |
| 19 Mon Oct | 57.23 | 77.44 | 73.16 |
| 16 Fri Oct | 55.90 | 77.65 | 73.48 |
| 15 Thu Oct | 58.50 | 77.88 | 73.84 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 72.12 and 200 EMA is at 67.51
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Thu Oct | 58.36 | 72.12 | 67.51 |
| 21 Wed Oct | 58.84 | 72.15 | 67.6 |
| 20 Tue Oct | 58.92 | 72.19 | 67.69 |
| 19 Mon Oct | 57.23 | 72.24 | 67.78 |
| 16 Fri Oct | 55.90 | 72.28 | 67.89 |
| 15 Thu Oct | 58.50 | 72.34 | 68.01 |
Vericel Corporation has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Vericel Corporation, about 19.57% more returns!
Arrowhead Pharmaceuticals has performed better than Sutro Biopharma in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Nucana Plc in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arvinas Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Arvinas Inc, about 13.18% more returns!
Corcept Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 4.06% more returns!
Diamedica Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Diamedica Therapeutics, about 20.16% more returns!
Dexcom Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Dexcom Inc, about 1.89% more returns!
Fate Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Fate Therapeutics, about 1.26% more returns!
Arrowhead Pharmaceuticals has performed better than Fortress Biotech in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Henry Schein has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Henry Schein, about 11.04% more returns!
Icu Medical has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Icu Medical, about 13.52% more returns!
Kamada has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Kamada, about 0.12% more returns!
Kura Oncology has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 3.01% more returns!
Arrowhead Pharmaceuticals has performed better than Mustang Bio in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Meiragtx Holdings has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 1.02% more returns!
Moderna Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Moderna Inc, about 13.35% more returns!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Arrowhead Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arrowhead Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arrowhead Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 58.87 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
